Ozempic and Wegovy: Cancer's Newest Foes in the Ring

Buckle up, folks! A dazzling new study reveals that Ozempic and Wegovy, the diabetes powerhouses, might just be the unexpected heroes in the battle against cancer. Unveiled at the 2026 ASCO Annual Meeting, these GLP-1 drugs showed they can slow cancer’s progress, giving oncologists a reason to raise their eyebrows. But hold your applause; more research is needed to see if they’re the real McCoy or just another flash in the pan.